SCHEMBL21633010

SCHEMBL21633010

CNCC[C@@H](Oc1ccccc1NCCN1CCC(c2ccccc2)CC1)c1cccs1

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ CARM1 Q86X55 1/20 0.51
▸ PRMT6 Q96LA8 1/20 0.51
▸ SLC6A2 P23975 10/20 0.50
▸ SLC6A4 P31645 8/20 0.50
▸ SLC6A3 Q01959 8/20 0.50
▸ MLNR O43193 1/20 0.50
▸ CACNA1F O60840 1/20 0.50
▸ CYP1A2 P05177 1/20 0.50
▸ ADRB1 P08588 1/20 0.50
▸ CYP3A4 P08684 1/20 0.50
▸ HTR1A P08908 1/20 0.50
▸ GAA P10253 1/20 0.50
▸ CYP2D6 P10635 1/20 0.50
▸ CYP2C9 P11712 1/20 0.50
▸ DRD2 P14416 1/20 0.50
▸ KCNE1 P15382 1/20 0.50
▸ ADRA2B P18089 1/20 0.50
▸ ADRA2C P18825 1/20 0.50
▸ HTR2A P28223 1/20 0.50
▸ HTR2C P28335 1/20 0.50

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21633011 1.00 CARM1 (0.51) CARM1PRMT6SLC6A2SLC6A4SLC6A3
SCHEMBL21632820 0.91 SLC6A2 (0.51) SLC6A2SLC6A4SLC6A3MLNRCACNA1F
SCHEMBL21632819 0.91 SLC6A2 (0.51) SLC6A2SLC6A4SLC6A3MLNRCACNA1F
SCHEMBL21633109 0.86 SLC6A2 (0.51) CARM1PRMT6SLC6A2SLC6A4SLC6A3
SCHEMBL21632830 0.84 SLC6A3 (0.47) SLC6A2SLC6A4SLC6A3MLNRCACNA1F
SCHEMBL21632942 0.84 SLC6A2 (0.53) CARM1PRMT6SLC6A2SLC6A4SLC6A3
SCHEMBL21633140 0.79 DRD2 (0.47) CARM1PRMT6SLC6A2SLC6A4SLC6A3
SCHEMBL21632858 0.79 CACNA2D1 (0.52) SLC6A2SLC6A4SLC6A3MLNRCACNA1F
SCHEMBL21632821 0.78 SLC6A2 (0.52) SLC6A2SLC6A4SLC6A3MLNRCACNA1F
SCHEMBL21118579 0.77 SLC6A4 (0.61) SLC6A2SLC6A4SLC6A3MLNRCACNA1F

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2020021021-A1 ORTHO SUBSTITUTED PHENOXYPROPYLAMINO AND BENZYLOXYPROPYLAMINO DERIVATIVES HAVING MULTIMODAL ACTIVITY AGAINST PAIN ESTEVE PHARMACEUTICALS, S.A. (ES) 2020-01-30 — — WO claimed
WO-2020021021-A1 ORTHO SUBSTITUTED PHENOXYPROPYLAMINO AND BENZYLOXYPROPYLAMINO DERIVATIVES HAVING MULTIMODAL ACTIVITY AGAINST PAIN ESTEVE PHARMACEUTICALS, S.A. (ES) 2020-01-30 — — WO disclosed
Send feedback